Cedirogant | Interleukin Related interleukin-related.com

Product Name :
Cedirogant

Search keywords :
Cedirogant

drugId :
null

Target Vo:
Nuclear receptor ROR-gamma

Target Vo Short Name :
RORG

Moa_Name:
Nuclear receptor ROR-gamma antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Inventiva Pharma

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Hepatic Insufficiency

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
LIAS Antibody
TOP2A Antibody
FNDC5 Antibody: FNDC5 Antibody is an unconjugated, approximately 12/20 kDa, rabbit-derived, anti-FNDC5 polyclonal antibody. FNDC5 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, chicken, dog, rabbit background without labeling.

Author: Interleukin Related

Related Posts